This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

American Diabetes Association Of Greater New York, Celebrates Alert Day With Walgreens, Duane Reade Challenge

NEW YORK, March 26, 2013 /PRNewswire-USNewswire/ -- Tuesday, March 26, 2013, is the 25 th Annual American Diabetes Association Alert Day, a one-day, "wake-up call" asking the American public to take the Diabetes Risk Test to find out if they are at risk for developing type 2 diabetes.   Americans are urged to take the Diabetes Risk Test on American Diabetes Association Alert Day® and to share it with everyone they care about to find out if they are at risk for developing type 2 diabetes.

On Alert Day, Walgreen Co. plans a fundraising challenge with its Walgreens and Duane Reade stores in metropolitan New York to support the activities of the American Diabetes Association Greater New York area.

The contest was announced by Skip Bourdo, Walgreens' market vice president for New York and Connecticut, and Greg Calvano, senior director of store operations for Duane Reade, at the Walgreens store in Times Square.

Under the challenge, announced Tuesday, approximately 500 Walgreens and Duane Reade stores in metro New York will join together to challenge their districts to see who will have the largest percentage increase in total funds raised from last year's challenge, which also benefited the American Diabetes Association of Greater New York.

Duane Reade and Walgreens will conduct a fall point of purchase campaign.

In addition, Walgreens has pledged its support of the "New York Area Step Out: Walk to Stop Diabetes" events through a grassroots activation of local community leaders. Walgreens will also display Alert Day information on the digital billboards at its Times Square store.

Click here, to view the ADA infographic on the economic burden of diabetes in New York and New Jersey.

To take the risk test, visit

SOURCE American Diabetes Association - New York City

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.92 0.19%
FB $118.57 0.84%
GOOG $698.21 0.75%
TSLA $238.50 -0.94%
YHOO $36.53 -0.19%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs